Revenue Expectations - Revenue for Q4 2024 is expected to be approximately $338.6 million, an increase of approximately 20.5% year-over-year, driven by organic growth and acquisitions [7]. - Full year 2024 revenue is expected to be approximately $1.228 billion, an increase of approximately 17.4% year-over-year [7]. - Initial guidance for full year 2025 revenue is projected to be between $1.330 billion and $1.350 billion [14]. Resident Count - Resident count is expected to be approximately 186,000 at the end of Q4 2024, an increase of approximately 14.1% year-over-year [7]. Net Income and Loss - Net income for Q4 2024 is expected to be between $10.1 million and $11.1 million, a decrease of $3.5 million to $4.5 million year-over-year [7]. - Full year 2024 net loss is expected to be between ($71.8) million and ($72.8) million, a decrease of $109.5 million to $110.5 million year-over-year [7]. Adjusted EBITDA - Adjusted EBITDA for Q4 2024 is expected to be approximately $25.9 million, an increase of approximately 30.3% year-over-year [7]. - Adjusted EBITDA for the full year 2024 is expected to be approximately $90.8 million, an increase of approximately 19.2% year-over-year [8]. - Initial guidance for full year 2025 Adjusted EBITDA is projected to be between $97.0 million and $101.0 million [14]. Financial Results Announcement - The company plans to announce complete Q4 and full year 2024 financial results on March 26, 2025 [10].
Guardian Pharmacy Services, Inc.(GRDN) - 2024 Q4 - Annual Results